Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | FASN | P49327 | 15/20 | 0.39 |
| ▸ | KDM2B | Q8NHM5 | 2/20 | 0.39 |
| ▸ | CCNC | P24863 | 1/20 | 0.39 |
| ▸ | CDK8 | P49336 | 1/20 | 0.39 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18082351 | 1.00 | ALDH1A1 (0.40) | ALDH1A1FASNKDM2BCCNCCDK8 | |
| SCHEMBL22910558 | 0.90 | ENPP2 (0.43) | ALDH1A1FASN | |
| SCHEMBL18082353 | 0.90 | ENPP2 (0.43) | ALDH1A1FASN | |
| SCHEMBL16759796 | 0.88 | ALDH1A1 (0.36) | ALDH1A1FASNKDM2BCCNCCDK8 | |
| SCHEMBL16759836 | 0.86 | NPC1 (0.46) | ALDH1A1 | |
| SCHEMBL22911062 | 0.86 | NPC1 (0.46) | ALDH1A1 | |
| SCHEMBL22911124 | 0.84 | MEN1 (0.42) | KDM2B | |
| SCHEMBL16759923 | 0.84 | NPC1 (0.38) | KDM2B | |
| SCHEMBL22911001 | 0.84 | NPC1 (0.38) | KDM2B | |
| SCHEMBL16759933 | 0.84 | MEN1 (0.42) | KDM2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210015792-A1 | OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL | HOFFMANN-LA ROCHE INC. (US) | 2021-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210015792-A1 | OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL | NPY1R, NPY2R, DECR1 | ALDH1A1 607/4885FASN 2871/4885KDM2B 793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.